1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ghana Pharmaceuticals and Healthcare Report Q4 2016

Ghana Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 84 pages

Includes 3 FREE quarterly updates


BMI View:

Ghana remains an attractive investment prospect for foreign drugmakers operating in Sub- Saharan Africa, and stabilising the national health insurance scheme provides an upside risk to our outlook for the pharmaceutical sector. The Ghanaian government is actively making progress towards fulfilling its ambition of being the Economic Communities of West African States (ECOWAS) hub for pharmaceutical and healthcare investment. Headline Expenditure Projections Pharmaceuticals: GHS1.18bn (USD310mn) in 2015 to GHS1.30bn (USD320mn) in 2016; +10.9% in local currency terms and +4.3% in US dollar terms. Forecast in line with Q316. Healthcare: GHS4.39bn (USD1.16bn) in 2015 to GHS4.78bn (USD1.19bn) in 2016; +8.9% in local currency terms and +2.4% in US dollar terms. Forecast in line with Q316.

Table Of Contents

Ghana Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ghana 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ghana 2012-2020) 15
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 26
OTC Drug Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Ghana 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Ghana 2014-2020) 32
Industry Risk/Reward Index 33
Middle East and Africa Risk/Reward Index - Q4 2016 33
Ghana Risk/Reward Index 41
Rewards 41
Risks 42
Regulatory Review 44
Intellectual Property Issues 46
Pricing And Reimbursement Regime 46
Market Overview 49
Healthcare Sector 50
Table: Healthcare Resources (Ghana 2010-2015) 53
Table: Healthcare Personnel (Ghana 2010-2015) 54
Table: Healthcare Activity (Ghana 2010-2015) 54
Research and Development 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Market Activity 64
Generic Drugmakers 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 65
Company Profile 66
Ayrton Drug Manufacturing Company (Adcock Ingram) 66
Danadams 69
Demographic Forecast 73
Table: Population Headline Indicators (Ghana 1990-2025) 74
Table: Key Population Ratios (Ghana 1990-2025) 74
Table: Urban/Rural Population and Life Expectancy (Ghana 1990-2025) 75
Table: Population By Age Group (Ghana 1990-2025) 75
Table: Population By Age Group % (Ghana 1990-2025) 76
Glossary 78
Methodology 80
Pharmaceutical Expenditure Forecast Model 80
Healthcare Expenditure Forecast Model 80
Notes On Methodology 81
Risk/Reward Index Methodology 82
Index Overview 83
Table: Pharmaceutical Risk/Reward Index Indicators 83
Indicator Weightings 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.